PATENT CLAIM ANALYSIS

Application Number: 15756454
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "021500"]

Abstract:
The disclosure relates to a pharmaceutical composition comprising any one or combination of PIF peptides or analogs or pharmaceutically acceptable salts thereof. Methods of treating autoimmune disease using the one or a combination of PIF peptide or analogs thereof or pharmaceutically acceptable salts thereof is also disclosed.

Claim (Index 45):
A composition comprising a PIF analog comprising an amino acid sequence that is at least 93% homologous to SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 88.0
- Lexical Diversity: 1.58065
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14009505', '14795581', '12786290', '11381818', '15474639']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7496209775786051
- 35 USC 102 Novelty (BERT): 0.5296334534888207
- Combined Prediction Score: 0.7276222251696267
- Mean Citation Score: 309.377716
- Max Citation Score: 348.2711
- Similarity Product: 213.37081402309536

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test